9th Annual Biomarkers Congress
Novel Vaccines: Adjuvants & Delivery Systems


Cambridge, Massachusetts
http://www.healthtech.com/imt/adj/
Novel Vaccines: Adjuvants & Delivery Systems 

Schedule of Presentations:

Wednesday, August 18, 2010
12:15:00 Registration
13:40:00 TOLL-LIKE RECEPTOR TECHNOLOGY
13:45:00 Chairperson’s Opening Remarks Susan Dana Jones
13:50:00 OPENING KEYNOTE PRESENTATION | Cytokines and Toll-Like Receptor Ligands as Adjuvants to Improve the Quality as well as Quantity of T Cell Immune Responses
14:30:00 Modulating Vaccine Responses with Innate Immunity Bali Pulendran
15:00:00 TLR3 Adjuvants Improve Oral Gene-Based Immunization Sean Tucker
15:30:00 Ice Cream Bar Refreshment Break with Exhibit and Poster Viewing
16:10:00 ENHANCING THE IMMUNE RESPONSE
16:15:00 Toll-Like Receptor 4: The Use of MPL in Vaccines – Efficacy and Safety Evaluation Nathalie Garçon
16:45:00 Enhancement of Response to Vaccines with the Use of an Immune Modulating Peptide, Thymosin Alpha 1 Israel Rios
17:15:00 Vaccine Immune-Enhancing Delivery Systems: From Danger Signals to a Nutritive Approach in Vaccine and Adjuvant Design Michael Vajdy
17:45:00 Vaccine Adjuvants and Regulatory Considerations William M. Egan
18:15:00 End of Day
Thursday, August 19, 2010
07:30:00 Morning Coffee (Breakfast Sponsored Presentation Opportunity Available)
08:20:00 DNA VACCINES
08:25:00 Chairperson’s Remarks
08:30:00 Heterologous Prime-Boost Vaccines for HIV Vaccine Development Shan Lu
09:00:00 Designing Smarter Adenoviral Vector Delivery of Vaccines: What Has Translated Successfully into Humans Alfredo Nicosia
09:30:00 SynCon DNA Vaccines for Emerging Infectious Diseases
10:00:00 Networking Coffee Break
10:25:00 MODES OF DELIVERY
10:30:00 The Pharmajet Needle-Free System for Standard Delivery of H1N1 Flu Vaccines and Future Applications Enabled by Intra-Dermal Delivery Linda McAllister
11:00:00 Mucosal Immunization against Vaginal Candida Infections Using Sap2 Recombinant Protein Delivered by Influenza Virosomes Rinaldo Zurbriggen
11:30:00 Intranasal Nanoemulsion Adjuvanted Influenza Vaccine – Dose Range Efficacy and Toxicity Studies Tarek Hamouda
12:00:00 Sponsored Presentation by Mucosis B.V. To Be Announced
12:15:00 Luncheon Presentation (Sponsorship Opportunity Available) or Lunch on Your Own
13:40:00 PARTICULATE DELIVERY
13:45:00 Chairperson’s Remarks
13:50:00 How VLPs Develop Their Efficacy Thomas Stauffer
14:20:00 Synthetic Virus-Like Particle (SVLP) Technology in Synthetic Vaccine Design Arin Ghasparian
14:50:00 Lecithin Nanoparticles as an Adjuvant for Vaccines Zhengrong Cui
15:20:00 Networking Refreshment Break
15:30:00 INNOVATIONS TO ENHANCE SAFETY
15:35:00 Adjuvantation of a Vaccine without Adjuvant Injection Mei X. Wu
16:05:00 Clinical Safety of the ISCOMATRIX Adjuvant Marli Watt
16:35:00 End of ImVacS
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.